---
title: "Tuoshan: Recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251332691.md"
description: "On the evening of August 3rd, Tuoshan announced that the cumulative deviation value of the closing price decline of its stock exceeded 20% over three consecutive trading days, which constitutes an abnormal fluctuation in stock trading. The company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment"
datetime: "2025-08-03T09:31:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251332691.md)
  - [en](https://longbridge.com/en/news/251332691.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251332691.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/251332691.md) | [繁體中文](https://longbridge.com/zh-HK/news/251332691.md)


# Tuoshan: Recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment

On the evening of August 3rd, Tuoshan announced that the cumulative deviation value of the closing price decline of its stock exceeded 20% over three consecutive trading days, which constitutes an abnormal fluctuation in stock trading. The company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment

### Related Stocks

- [Tuoshan (001226.CN)](https://longbridge.com/en/quote/001226.CN.md)

## Related News & Research

- [Evergrande Property Services Updates Investors on Ongoing Takeover Talks](https://longbridge.com/en/news/278719332.md)
- [Hyosung Heavy Industries wins 142.5 billion won order](https://longbridge.com/en/news/278698660.md)
- [Drakkar BidCo Extends Rana Gruber Takeover Offer Deadline by One Week](https://longbridge.com/en/news/278582901.md)
- [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/en/news/278372421.md)
- [Is Corteva (CTVA) Fairly Priced After Strong 1-Year Share Price Performance](https://longbridge.com/en/news/278534641.md)